
SynBioBeta Speaker
Benedetta Di Robilant
ProMIND Therapeutics
Co-founder & CEO
Dr. Benedetta di Robilant is a biotech entrepreneur and scientist with a PhD in Immunology and a Postdoctoral Fellowship at Stanford University, where she studied stem cells, aging, and age-related diseases including Down syndrome, Alzheimer’s disease, and fibrosis. She has experience translating academic discoveries into biotech ventures. Dr. di Robilant previously founded Dorian Therapeutics, a Stanford spinout acquired by Altos Labs and is now the co-founder and CEO of ProMIND Therapeutics, developing first-in-class therapies for neurodegenerative and neurodevelopmental disorders. Her work sits at the intersection of aging, neuroscience and translational medicine, with a focus on advancing fundamental discoveries toward meaningful patient impact.








































